Ganoderma tsugae extract inhibits growth of her2-overexpressing cancer cells via modulation of HER2/PI3K/Akt signaling pathway

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Kuo, Han Peng ^a   Hsu, Shih Chung ^b   Ou, Chien Chih ^c   Li, Jhy Wei ^d   Tseng, Hsiu Hsueh ^e   Chuang, Tzu Chao ^f   Liu, Jah Yao ^g   Chen, Shih Jung ^h   Su, Muh Hwan ⁱ   Cheng, Yung Chi ^j   Chou, Wei Yuan ^e   Kao, Ming Ching ^a,e  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b Kang Ning Junior College of Medical Care and Management   (Taiwan)

^c SynCore Bio   (Taiwan)

^d Da Chien General Hospital   (Taiwan)

^e NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^f TAMKANG UNIVERSITY   (Taiwan)

^g TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^h Luo Gui Ying Fungi Agriculture Farm   (Taiwan)

ⁱ Sinphar Group R and D Center   (Taiwan)

^j YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GANODERMA LUCIDUM EXTRACT; PACLITAXEL; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ADJUVANT CHEMOTHERAPY; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE ARREST; GANODERMA LUCIDUM; GANODERMA TSUGAE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL;

EID: 84877277197     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/219472     Document Type: Article

References (35)

1. Baselga J., Swain S. M., Novel anticancer targets: revisiting ERBB2 and discovering ERBB3. Nature Reviews Cancer 2009 9 7 463 475 2-s2.0-67649472398 10.1038/nrc2656
2. Wolff A. C., Hammond M. E. H., Schwartz J. N., Hagerty K. L., Alfred D. C., Cote R. J., Dowsett M., Fitzgibbons P. L., Hanna W. M., Langer A., McShane L. M., Paik S., Pegram M. D., Perez E. A., Press M. F., Rhodes A., Sturgeon C., Taube S. E., Tubbs R., Vance G. H., Van De Vijver M., Wheeler T. M., Hayes D. F., American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Archives of Pathology and Laboratory Medicine 2007 131 1 18 43 2-s2.0-33846568336 (Pubitemid 46174133)
3. Verri E., Guglielmini P., Puntoni M., Perdelli L., Papadia A., Lorenzi P., Rubagotti A., Ragni N., Boccardo F., HER2/neu oncoprotein overexpression in epithelial ovarian cancer: evaluation of its prevalence and prognostic significance: clinical study. Oncology 2005 68 2-3 154 161 2-s2.0-23844485690 10.1159/000086958 (Pubitemid 41158970)
4. Yu D., Hung M. C., Overexpression of ErbB2 in cancer and ErbB2-targeting strategies. Oncogene 2000 19 53 6115 6121 2-s2.0-0034638917 10.1038/sj.onc. 1203972 (Pubitemid 32059461)
5. Ju J. H., Jeon M. J., Yang W., Lee K. M., Seo H. S., Shin I., Induction of apoptotic cell death by Pharbitis nil extract in HER2-overexpressing MCF-7 cells. Journal of Ethnopharmacology 2011 133 1 126 131 2-s2.0-78650680189 10.1016/j.jep.2010.09.021
6. Kuo H. P., Chuang T. C., Yeh M. H., Hsu S. C., Way T. D., Chen P. Y., Wang S. S., Chang Y. H., Kao M. C., Liu J. Y., Growth suppression of HER2-overexpressing breast cancer cells by berberine via modulation of the HER2/PI3K/Akt signaling pathway. Journal of Agricultural and Food Chemistry 2011 59 15 8216 8224 2-s2.0-79961132108 10.1021/jf2012584
7. National Commission of Chinese Pharmacopoeia, Pharmacopoeia of Peoples Republic of China 2010 Beijing, China China Medical Science and Technology Press
8. Da J., Wu W. Y., Hou J. J., Comparison of two officinal Chinese Pharmacopoeia species of Ganoderma based on chemical research with multiple technologies and chemometrics analysis. Journal of Chromatography A 2012 1222 59 70
9. Zhou X., Lin J., Yin Y., Ganodermataceae: natural products and their related pharmacological functions. The American Journal of Chinese Medicine 2007 35 4 559 574 (Pubitemid 47307695)
10. Lai N. S., Lin R. H., Lai R. S., Kun U. C., Leu S. C., Prevention of autoantibody formation and prolonged survival in New Zealand Black/New Zealand White F1 mice with an ancient Chinese herb, Ganoderma tsugae. Lupus 2001 10 7 461 465 2-s2.0-0034924141 10.1191/096120301678416006 (Pubitemid 32675044)
11. Wu Y. W., Chen K. D., Lin W. C., Effect of Ganoderma tsugae on chronically carbon tetrachloride-intoxicated rats. The American Journal of Chinese Medicine 2004 32 6 841 850 2-s2.0-10944244162 10.1142/S0192415X04002454 (Pubitemid 40012453)
12. Ko H. H., Hung C. F., Wang J. P., Lin C. N., Antiinflammatory triterpenoids and steroids from Ganoderma lucidum and G. tsugae. Phytochemistry 2008 69 1 234 239 2-s2.0-37148999071 10.1016/j.phytochem.2007.06.008 (Pubitemid 350256778)
13. Mau J. L., Lin H. C., Chen C. C., Antioxidant properties of several medicinal mushrooms. Journal of Agricultural and Food Chemistry 2002 50 21 6072 6077 2-s2.0-0037048733 10.1021/jf0201273 (Pubitemid 35155337)
14. Yue G. G. L., Fung K. P., Tse G. M. K., Leung P. C., Lau C. B. S., Comparative studies of various Ganoderma species and their different parts with regard to their antitumor and immunomodulating activities in vitro. Journal of Alternative and Complementary Medicine 2006 12 8 777 789 2-s2.0-33845591207 10.1089/acm.2006.12.777 (Pubitemid 44934092)
15. 2/M cell cycle arrest. Journal of Ethnopharmacology 2008 120 3 394 401 2-s2.0-56349126537 10.1016/j.jep.2008.09. 025 (Pubitemid 50332981)
16. Hsu S. C., Ou C. C., Chuang T. C., Li J. W., Lee Y. J., Wang V., Liu J. Y., Chen C. S., Lin S. C., Kao M. C., Ganoderma tsugae extract inhibits expression of epidermal growth factor receptor and angiogenesis in human epidermoid carcinoma cells: in vitro and in vivo. Cancer Letters 2009 281 1 108 116 2-s2.0-67349281217 10.1016/j.canlet.2009.02.032
17. Gan K. H., Fann Y. F., Hsu S. H., Kuo K. W., Lin C. N., Mediation of the cytotoxicity of lanostanoids and steroids of Ganoderma tsugae through apoptosis and cell cycle. Journal of Natural Products 1998 61 4 485 487 2-s2.0-0005193557 10.1021/np9704664 (Pubitemid 28217510)
18. Yu Y. H., Kuo H. P., Hsieh H. H., Ganoderma tsugae induces S phase arrest and apoptosis in doxorubicin-resistant lung adenocarcinoma H23/0. 3 cells via modulation of the PI3K/Akt signaling pathway. Evidence-Based Complementary and Alternative Medicine 2012 2012 13 371286 10.1155/2012/371286
19. Tilton R., Paiva A. A., Guan J. Q., Marathe R., Jiang Z., van Eyndhoven W., Bjoraker J., Prusoff Z., Wang H., Liu S. H., Cheng Y. C., A comprehensive platform for quality control of botanical drugs (PhytomicsQC): a case study of Huangqin Tang (HQT) and PHY906. Chinese Medicine 2010 5, article 30 2-s2.0-77955684821 10.1186/1749-8546-5-30
20. Hu B., An H. M., Shen K. P., Polygonum cuspidatum extract induces anoikis in hepatocarcinoma cells associated with generation of reactive oxygen species and downregulation of focal adhesion kinase. Evidence-Based Complementary and Alternative Medicine 2012 2012 9 607675 10.1155/2012/607675
21. Chuang T. C., Hsu S. C., Cheng Y. T., Magnolol down-regulates HER2 gene expression, leading to inhibition of HER2-mediated metastatic potential in ovarian cancer cells. Cancer Letters 2011 311 1 11 19
22. Kuo H. P., Chuang T. C., Tsai S. C., Berberine, an isoquinoline alkaloid, inhibits the metastatic potential of breast cancer cells via Akt pathway modulation. Journal of Agricultural and Food Chemistry 2012 60 38 9649 9658
23. Li J. W., Chuang T. C., Yang A. H., Hsu C. K., Kao M. C., Clinicopathological relevance of HER2/neu and a related gene-protein cubic regression correlation in colorectal adenocarcinomas in Taiwan. International Journal of Oncology 2005 26 4 933 943 2-s2.0-22844449310
24. Boh B., Berovic M., Zhang J., Zhi-Bin L., Ganoderma lucidum and its pharmaceutically active compounds. Biotechnology Annual Review 2007 13 265 301 2-s2.0-34548598182 10.1016/S1387-2656(07)13010-6 (Pubitemid 47387127)
25. Yu D., Liu B., Tan M., Li J., Wang S. S., Hung M. C., Overexpression of c-erbB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1-independent mechanisms. Oncogene 1996 13 6 1359 1365 2-s2.0-0029830451 (Pubitemid 26343590)
26. Shiu L. Y., Liang C. H., Huang Y. S., Sheu H. M., Kuo K. W., Downregulation of HER2/neu receptor by solamargine enhances anticancer drug-mediated cytotoxicity in breast cancer cells with high-expressing HER2/neu. Cell Biology and Toxicology 2008 24 1 1 10 2-s2.0-37749030574 10.1007/s10565-007-9010-5
27. Grana X., Reddy E. P., Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 1995 11 2 211 219 2-s2.0-0029119740
28. Collins K., Jacks T., Pavletich N. P., The cell cycle and cancer. Proceedings of the National Academy of Sciences United States of America 1997 94 7 2776 2778 (Pubitemid 27157209)
29. Imai K., Takaoka A., Comparing antibody and small-molecule therapies for cancer. Nature Reviews Cancer 2006 6 9 714 727 2-s2.0-33747855481 10.1038/nrc1913 (Pubitemid 44286003)
30. Chandarlapaty S., Sawai A., Ye Q., Scott A., Silinski M., Huang K., Fadden P., Partdrige J., Hall S., Steed P., Norton L., Rosen N., Solit D. B., SNX2112, a synthetic heat shock protein 90 inhibitor, has potent antitumor activity against HER kinase-dependent cancers. Clinical Cancer Research 2008 14 1 240 248 2-s2.0-40749103835 10.1158/1078-0432.CCR-07-1667 (Pubitemid 351378001)
31. Klapper L. N., Waterman H., Sela M., Yarden Y., Tumor-inhibitory antibodies to HER-2/ErbB-2 may act by recruiting c-Cbl and enhancing ubiquitination of HER-2. Cancer Research 2000 60 13 3384 3388 2-s2.0-0034234854 (Pubitemid 30482151)
32. Lam P. B., Burga L. N., Wu B. P., Hofstatter E. W., Lu K. P., Wulf G. M., Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stability. Molecular Cancer 2008 7, article 91 2-s2.0-61349151785 10.1186/1476-4598-7-91
33. Miles D. W., Harris W. H., Gillett C. E., Effect of c-erbB2 and estrogen receptor status on survival of women with primary breast cancer treated with adjuvant cyclophosphamide/methotrexate/fluorouracil. International Journal of Cancer 1999 84 4 354 359 (Pubitemid 29337119)
34. Liu J., He C., Zhou K., Coptis extracts enhance the anticancer effect of estrogen receptor antagonists on human breast cancer cells. Biochemical and Biophysical Research Communications 2009 378 2 174 178
35. Takara K., Horibe S., Obata Y., Yoshikawa E., Ohnishi N., Yokoyama T., Effects of 19 herbal extracts on the sensitivity to paclitaxel or 5-fluorouracil in HeLa cells. Biological and Pharmaceutical Bulletin 2005 28 1 138 142 2-s2.0-18444406248 10.1248/bpb.28.138 (Pubitemid 40879798)